| S2259 |
Aloe-emodin
|
Aloe-emodin (NSC 38628, Rhabarberone) is an interferon-inducing agent with IC50 of about 1 μg/mL for JEV and of about 0.33 μg/mL for EV71.
|
-
Journal of Traditional and Complementary Medicine, January 31 2015, 96-99
-
PLoS One, April 19 2019, e0215664
-
PLoS One, 2019, 14(4):e0215664
|
|
| S5020 |
Tilorone dihydrochloride
|
Tilorone dihydrochloride is a broad-spectrum, orally active antiviral agent that activates interferon production. It has antitumor, anti-inflammatory properties.
|
|
|
| S1537 |
Vadimezan (DMXAA)
|
Vadimezan (DMXAA) is a vascular disrupting agents (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 μM and IC50 of 62.5 μM in cell-free assays, respectively. It is also a STING agonist with potential antineoplastic activity, potently inducing IFN-β but relatively low TNF-α expression in vitro. This compound has antiviral activity. Phase 3.
|
-
Cell Chem Biol, 2025, 32(2):280-290.e14
-
Commun Biol, 2025, 8(1):1470
-
Front Pharmacol, 2025, 16:1528459
|
|
| S8133 |
Resiquimod (R-848)
|
Resiquimod (R-848, S28463) is an immune response modifier that acts as a potent TLR 7/TLR 8 agonist, inducing the upregulation of cytokines such as TNF-α, IL-6 and IFN-α. This compound reduces hepatitis C virus (HCV) infection. Phase 2.
|
-
Nature, 2025, 644(8078):1058-1068
-
J Virol, 2025, e0128025.
-
Int J Nanomedicine, 2024, 19:3589-3605
|
|
| S8954 |
G10 (STING agonist-1)
|
G10 (STING agonist-1) is a novel human-specific STING agonist that triggers IFN regulatory factor 3 (IRF3)/ type I interferon (IFN)-associated transcription in human fibroblasts. This compound potently reduces growth of Chikungunya virus (CHIKV) with IC90 of 8.01 μM and blocks replication of Alphavirus species Venezuelan Equine Encephalitis Virus (VEEV) with IC90 of 24.57 μM.
|
-
International Journal of Biological Sciences, 2023, 3428-3440
-
Int J Biol Sci, 2023, 19(11):3428-3440
-
Dissertation, Heidelberg University, 2023, 34
|
|
| S7905 |
3',3'-cGAMP
|
3',3'-cGAMP (3',3'-cyclic GMP-AMP, Cyclic GMP-AMP, cGAMP) activates the endoplasmic reticulum (ER)-resident receptor stimulator of interferon genes (STING), thereby inducing an antiviral state and the secretion of type I IFNs.
|
|
|